Podcasts about respiratory

In this episode of the Wise Divine Women podcast, Dana Irvine and Dr. John Oertle discuss the latest advancements in breast cancer research, focusing on recurrence rates, the role of circulating tumor cells, and the importance of optimizing the immune system. Dr John's main goal is to enlighten Americans and people worldwide that there is a groundbreaking study published in Nature is shining a light on a hidden risk: respiratory infections can reawaken dormant breast cancer cells, accelerating recurrence. Read the article and research links They explore the impact of environmental toxins on cancer, the necessity of early detection through testing, and the effects of respiratory infections on cancer patients. The conversation also touches on the role of vaccines in immune response and the potential future of peptides in cancer treatment, emphasizing the need for advocacy in accessing innovative therapies.Envita Medical Center Want to listen to our first episode together? Wise Divine Women podcast, host Dana Irvine speaks with Tammy Morrow and Dr. John Oertle about the intersection of faith, health, and innovative cancer treatmentsTakeawaysRecurrence rates for stage one breast cancer can be as high as 20-30%.Circulating tumor cells can be detected even in early-stage cancers.Optimizing the immune system is crucial for cancer patients.Environmental toxins may trigger cancer development.Testing for circulating tumor cells can aid in early detection.Respiratory infections can impact cancer recurrence and growth.Vaccines may enhance immune response in cancer treatment.Peptides show promise in cancer treatment but require careful dosing.Advocacy for access to innovative treatments is essential.Education and awareness are key for patients in managing their health.Chapters00:00 Introduction to Breast Cancer Research01:04 Understanding Recurrence Rates in Breast Cancer03:51 The Role of Circulating Tumor Cells09:38 Maximizing Outcomes Through Immune System Support17:18 Challenges in Oncology: Insurance and Testing21:20 Environmental Toxins and Cancer Prevention23:43 Impact of Respiratory Infections on Cancer25:15 The Role of IL-6 in Cancer Growth28:25 Monitoring Cancer Recurrence Post-Infection29:37 Vaccines and Immune Response33:14 Immunotherapy and Immune System Dynamics37:45 The Future of Peptides in Cancer Treatment46:05 Access to Preventive HealthcareI hope you enjoyed this episode! Please leave a review and share with friends and family Want to learn more about my offerings? Please visit danairvine.com I invite you to schedule a Soul Session to lern about how we can work together or dive right in and book a Women's Hormone Transformation

Martin is a renowned authority in Breath Science, bringing together an impressive blend of expertise as a Respiratory and Sleep Scientist, Exercise Physiologist, and Behavioural Science Practitioner. With over 15 years of experience in research, clinical work, and training, Martin is not only a consultant, scientist and educator but also a passionate advocate for healthy, connected living. Martin is the founder of Performance Through Health and The School of Breath Science. Who is committed to his vision of creating a world where people can achieve optimal health and happiness his unique blend of academic rigor, clinical expertise, and personal passion positions him at the forefront of the Breath Science field, making him a trusted figure in helping others achieve their best health and raising the standard of scientific understanding in the breath and wellbeing space. SHOWNOTES:

Respiratory syncytial virus (RSV) continues to pose a serious health threat—particularly to infants, older adults, and immunocompromised individuals—making it critical for pharmacy professionals to stay up to date on prevention and treatment options. This episode covers the latest FDA-approved RSV therapies, including vaccines and monoclonal antibodies, while highlighting clinical pearls for use across care settings. Tune in to stay informed and better support patients during the upcoming respiratory season.HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTKalen Manasco, PharmD, BCPS, BCPPS, FCCP, FPPAProfessorUniversity of Florida College of PharmacyJoshua Davis Kinsey and Kalen Manasco have no relevant financial relationships with ineligible companies to disclose.  Pharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Differentiate between RSV vaccines and monoclonal antibody therapies, including their indications and target patient populations.2. Identify key counseling points and administration considerations associated with currently available RSV vaccines and monoclonal antibody therapies.0.05 CEU/0.5 HrUAN: 0107-0000-25-312-H01-PInitial release date: 11/3/2025Expiration date: 11/3/2026Additional CPE details can be found here.

Respiratory syncytial virus (RSV) continues to pose a serious health threat—particularly to infants, older adults, and immunocompromised individuals—making it critical for pharmacy professionals to stay up to date on prevention and treatment options. This episode covers the latest FDA-approved RSV therapies, including vaccines and monoclonal antibodies, while highlighting clinical pearls for use across care settings. Tune in to stay informed and better support patients during the upcoming respiratory season. HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTKalen Manasco, PharmD, BCPS, BCPPS, FCCP, FPPAProfessorUniversity of Florida College of PharmacyJoshua Davis Kinsey and Kalen Manasco have no relevant financial relationships with ineligible companies to disclose. Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Differentiate between RSV vaccines and monoclonal antibody therapies, including their indications and target patient populations.2. Identify key counseling points and administration considerations associated with currently available RSV vaccines and monoclonal antibody therapies.0.05 CEU/0.5 HrUAN: 0107-0000-25-312-H01-PInitial release date: 11/3/2025Expiration date: 11/3/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

See omnystudio.com/listener for privacy information.

Send us a textOn this episode, we interview Dr. Wigdan Farah, a pulmonologist in Mayo Clinic's Division of Pulmonary & Critical Care Medicine to discuss several respiratory conditions seen commonly in pilots seeking medical certification -- then review aeromedical implications and requirements.

Porcine Reproductive and Respiratory syndrome, more commonly know as PRRS, is the most economically damaging disease to the US pork industry. According to studies done by Iowa State University, it is estimated that PRRS cost producers $1.2 billion dollars in 2024. That staggering statistic is exactly why Extension Swine Outreach Specialist Jeff Morris is invested in sharing information about the disease.See omnystudio.com/listener for privacy information.

Kyle & Ben discuss ways to progress athletes towards optimal breathing, from expanding tidal volume (depth of breaths) to maximizing respiratory frequency (breath rate).» Respiratory Roundtable [Ep.191]: https://www.youtube.com/watch?v=KMt5Hjf7zjY&t» Breathe Way Better with Kyle Ruth: https://www.youtube.com/watch?v=uhr1u23gw20&t» Watch on YouTube: https://youtu.be/f5BSJM2TY4Q» View All Episodes: https://zoarfitness.com/podcast/» Hire a Coach: https://www.zoarfitness.com/coach/» Shop Programs: https://www.zoarfitness.com/product-category/downloads/» Follow ZOAR Fitness on Instagram: https://www.instagram.com/zoarfitness/Support the show

On Friday, Oct. 17, the Physician Enterprise hosted a Grand Rounds session discussing evidence-based updates for respiratory immunization clinical guidelines. We also have this additional resource available related to fall viruses and immunizations:5-Minute Check In: Fall Viruses and Vaccinationshttps://youtu.be/PowPADYqzGA?si=x_G3XJY_335rcdW2

Guest: Sujith Cherian MD, FCCP, DAABIP Obesity impacts how the lungs function in a variety of ways, and understanding these impacts is essential for interpreting pulmonary function tests, identifying restrictive or obstructive patterns, and managing ventilation. Learn more with Dr. Sujith Cherian, who's an Associate Professor in the Divisions of Critical Care, Pulmonary, and Sleep Medicine at University of Texas Health-McGovern Medical School and the Director of Interventional Pulmonology and Pleural Diseases at Lyndon B. Johnson Hospital in Houston. He also spoke about this topic at the 2025 CHEST Annual Meeting.

Early detection saves lives, but today's tools are often invasive, slow, or used too late. In this episode, Breath Diagnostics CEO Ivan Lo explains how a non-invasive breath test can detect volatile organic compounds (VOCs) associated with disease—positioning breath as a first-line screen for early-stage lung cancer and potentially pneumonia and TB. We cover the science (why breath can capture near real-time biological change), sensitivity/specificity signals from 800+ patients, and a go-to-market/regulatory plan that prioritizes post-op pneumonia (shorter trials, no entrenched standard of care) before lung cancer screening. We also discuss platform economics (low-cost disposables, existing LC-MS infrastructure), trial scale and cost, and how breath could support ongoing monitoring after treatment. Investors get a clear view of timelines, risks, and upside; founders get lessons on platform positioning, capital efficiency, and sequencing indications. Highlights include...Why breath (VOCs) can surface disease signals minutes–hours after biological changeFirst-line screening thesis vs. liquid biopsy and CT workflowsEarly data: ~94% sensitivity / 85% specificity across 800+ patients (lung cancer context)Regulatory path: post-op pneumonia first (faster FDA route), lung cancer nextUnit economics: low-cost cartridge + existing LC-MS labs (hub-and-spoke)Clinical design: trial scale, costs, and companion-diagnostic “cocktail” potentialPlatform beyond oncology: pneumonia, TB, inflammation, RUO for pharmaChapters00:00 Intro & why early detection needs a rethink00:47 What Breath Diagnostics does (the “breath bag”)03:34 VOCs 101: why breath can be earlier than blood06:41 First-line screen vs. confirmatory tests08:19 Will this be ubiquitous at annual visits?11:53 Commercialization path & funding realities12:37 Pneumonia first: faster FDA route14:09 Lung cancer timeline & business model15:34 Hospital economics & pneumonia savings18:24 Trial scale/costs; disposable chip economics20:34 Team, funding strategy, and sequencing22:08 Early data and a “false negative” biopsy case24:12 TAM & eligibility (20M Americans qualify)25:06 What success looks like (2–3 years)27:00 Investor closing thoughts

In this week's episode, we spotlight the phenomenal egg-laying Chinese Goose, take a deep dive into the chicken's respiratory system, share our recipe for Pumpkin Scones, and find some retail therapy with vintage goose collectables. Grubbly Farms - click here for our affiliate link.https://www.anrdoezrs.net/click-100963304-15546963Pre and Probiotic and Vitamin and Electrolyte Powders!Bright and Early Coffee - use code CWTCL15 for 15% off of any bagged coffee. K Cups always ship free!https://brightandearlycoffee.com/Omlet Coops- Use Our Affiliate Link and COFFEE10 code for 10% off!https://tidd.ly/3Uwt8BfBreed Spotlight is sponsored by Murray McMurray Hatcheryhttps://www.mcmurrayhatchery.com/Metzer Farms Waterfowlhttps://www.metzerfarms.com/Nestera UShttps://nestera.us/cwtclUse our affiliate link above for 5% off your purchasePumpkin Chocolate Chip Scones - https://coffeewiththechickenladies.com/farm-fresh-egg-recipes/pumpkin-chocolate-chip-scones/CWTCL Websitehttps://coffeewiththechickenladies.com/CWTCL Etsy Shophttps://www.etsy.com/shop/CoffeeWChickenLadiesAs Amazon Influencers, we may receive a small commission from the sale of some items at no additional cost to consumers.CWTCL Amazon Recommendationshttps://www.amazon.com/shop/coffeewiththechickenladiesSupport the show

Dr. Marc Salzberg, President, CEO, and Chief Medical Officer at Airway Therapeutics, is developing a drug AT-100 to prevent bronchopulmonary dysplasia (BPD) in preterm infants, a severe condition with no existing treatment. These infants are at high risk for BPD because of a low level of a protective protein that reduces inflammation and clears infections from their underdeveloped lungs. The drug's mechanism of action suggests it has potential for treating other inflammatory conditions such as asthma, COPD, and severe pneumonia. Marc explains, "We're focusing on developing drugs or interventions for severe respiratory conditions for prevention or treatment of severe respiratory conditions. And our first project is focusing on the respiratory condition that preterm neonates have, which is called bronchopulmonary dysplasia, and cannot be treated or prevented yet. It's a very severe condition. And that really triggered my interest in getting engaged because it's going to be a paradigm shift if we manage to bring this drug to market." "The protein that we're developing is an endogenous protein that we all have. In the past years or decade, it has been discovered that this protein has a very essential function in fighting inflammation and infection on a daily basis. Now, there are certain conditions or instances where the protein is low-functioning. For instance, in preterm-born babies, but also in adults with severe respiratory inflammation, with pneumonias, with asthma, or COPD. In all those cases where protein is low, those are the instances where you actually need it most. So, replacing it in those instances is a kind of logical rationale for the concept for the treatment that we're developing." #AirwayTherapeutics #BPD #InflammatoryDiseases #Zelpultidealfa #PrematureBabies #PretermBabies airwaytherapeutics.com Listen to the podcast here  

Dr. Marc Salzberg, President, CEO, and Chief Medical Officer at Airway Therapeutics, is developing a drug AT-100 to prevent bronchopulmonary dysplasia (BPD) in preterm infants, a severe condition with no existing treatment. These infants are at high risk for BPD because of a low level of a protective protein that reduces inflammation and clears infections from their underdeveloped lungs. The drug's mechanism of action suggests it has potential for treating other inflammatory conditions such as asthma, COPD, and severe pneumonia. Marc explains, "We're focusing on developing drugs or interventions for severe respiratory conditions for prevention or treatment of severe respiratory conditions. And our first project is focusing on the respiratory condition that preterm neonates have, which is called bronchopulmonary dysplasia, and cannot be treated or prevented yet. It's a very severe condition. And that really triggered my interest in getting engaged because it's going to be a paradigm shift if we manage to bring this drug to market." "The protein that we're developing is an endogenous protein that we all have. In the past years or decade, it has been discovered that this protein has a very essential function in fighting inflammation and infection on a daily basis. Now, there are certain conditions or instances where the protein is low-functioning. For instance, in preterm-born babies, but also in adults with severe respiratory inflammation, with pneumonias, with asthma, or COPD. In all those cases where protein is low, those are the instances where you actually need it most. So, replacing it in those instances is a kind of logical rationale for the concept for the treatment that we're developing." #AirwayTherapeutics #BPD #InflammatoryDiseases #Zelpultidealfa #PrematureBabies #PretermBabies airwaytherapeutics.com Download the transcript here  

In this episode of EMSconnect On Shift, Quinn dives deep into one of the most common and critical calls in prehospital care: respiratory emergencies. From asthma and COPD to CHF and pneumonia, Quinn breaks down the “Big 4” respiratory issues every EMS provider encounters and explores how to assess, treat, and manage these patients at the BLS level.Join us as we review key anatomy and physiology, discuss how to recognize respiratory distress before it becomes failure or arrest, and walk through scenario-based learning that challenges your clinical thinking. Whether it's setting up oxygen delivery systems, assisting with MDIs, or knowing when to call for ALS, this episode reinforces the importance of calm, calculated care when every breath counts.

Boswellia opens airways, reduces bronchial and sinus swelling... And don't miss the following topics that Terry will also discuss on this show: Obesity is Killing Us and Our Hearts Help for “Sundowning” How to Abuse Your Liver Herb of the Day: Ashwagandha 3 Unexpected Benefits of Vitamin D

In this episode of the RCP Medicine Podcast, Consultant Respiratory Physician Milind Savani joins Respiratory Registrar Daniella Draicchio and Foundation Doctor Masooma Ali to explore a compelling case of progressive breathlessness in a 45-year-old woman. What begins as a seemingly routine presentation unfolds into a diagnostic journey.Together, the team discusses the challenges of diagnosing chronic type 2 respiratory failure, the importance of recognising paradoxical breathing, and the role of non-invasive ventilation and surgical intervention. This episode is a masterclass in clinical reasoning, multidisciplinary collaboration, and the value of thorough bedside examination.ReferencesA retrospective cohort study of idiopathic diaphragmatic palsy: a diagnostic triad, natural history and prognosis ERJ Open Research 2021 00953-2020; DOI: https://doi.org/10.1183/23120541.00953-2020 Diagnosis and management of nontraumatic unilateral diaphragmatic paralysis (complete or partial) in adults - UpToDateTreatment of diaphragmatic paralysis using an expanded surgical protocol: review of the largest worldwide experience  European Respiratory Journal 2018 52 (suppl 62): PA806; DOI: https://doi.org/10.1183/13993003.congress-2018.PA806 Diaphragm dysfunction: how to diagnose and how to treat? Breathe 2025 21(1): 240218; DOI: https://doi.org/10.1183/20734735.0218-2024 This podcast has been made with an educational grant from Bristol-Myers Squibb Pharmaceuticals Limited (“BMS”). BMS has had no input or involvement in the design, development or content of the podcast whatsoever.RCP Links Education Events Membership Improving care Policy and campaigns RCP Social Media Instagram LinkedIn Facebook X Bluesky Music: Episode 50 onward - Bensound.com Episodes 1 - 49 'Impressive Deals' - Nicolai Heidlas

With the Wind with Dr. Paul – Show 186: Pediatric Perspectives: Respiratory Illness Preparedness – Deep Dive Into Iodine with David Brownstein, M.D. Presenters: Dr. Paul, David Brownstein, M.D. Length: Approximately 28 minutes ________________________________________ Summary: In this episode, Dr. Paul welcomes back David Brownstein, M.D., to take a deep dive into iodine's overlooked but essential role in human health. Dr. Brownstein shares decades of clinical insights into how iodine deficiency contributes to rising rates of cancer and chronic illness, explains the shortcomings of iodized salt, and emphasizes iodine's importance for children, pregnancy, and immune function. He also introduces his low-cost home respiratory preparedness protocol using nebulized iodine and peroxide. ________________________________________ Key Points (with time stamps): • 00:00:40 – Dr. Paul's Intro: Announcement about VAX FACTS availability and where to order. • 00:02:00 – Introduction of Dr. Brownstein: Overview of his integrative medical practice and focus on iodine's critical role in health. • 00:03:08 – Essential Role of Iodine: Dr. Brownstein explains iodine as a required nutrient for every cell, with major concentrations in glandular tissues. • 00:04:18 – Deficiency and Disease: How iodine deficiency leads to cysts, precancerous changes, and cancers of the thyroid, breast, ovaries, prostate, and pancreas. • 00:06:30 – Cancer Prevention: Evidence that iodine sufficiency may prevent or reverse disease pathways, including cancer. • 00:07:49 – Why We're Deficient: Soil depletion, industrial toxins, and halides (bromide, fluoride) contributing to widespread iodine deficiency. • 00:12:43 – Public Health History: The introduction of iodized salt in the 1920s, its impact on goiter prevention, and why iodized salt is still insufficient for overall health. • 00:19:20 – Case Study: Clinical experience showing breast tissue recovery and avoidance of surgery through iodine supplementation. • 00:21:35 – Use in Children: Safe dosing approaches for children and how iodine supports conditions like Hashimoto's. • 00:23:05 – Respiratory Preparedness Kit: Brownstein outlines his clinical protocol of nebulized iodine and hydrogen peroxide as a low-cost home therapy for respiratory illnesses, including COVID-19 and RSV. • 00:26:12 – Closing: Dr. Brownstein directs listeners to his website for more resources; Dr. Paul reminds viewers of VAX FACTS and Kids First 4Ever coaching. ______________

Host: Alli Howe Guest" Kathleen Satterfield Air date: Oct 13, 2025

Susanna Esposito joins Saranya Ravindran to explore how clinicians can distinguish viral from bacterial respiratory infections in children. From bronchiolitis management to targeted testing, stewardship strategies, and the role of vitamin D and point-of-care diagnostics, this episode unpacks evidence-based approaches to reduce unnecessary antibiotic use.  Timestamps:  00:00 – Introduction  02:00 – Respiratory infections  03:30 – Targeted testing  04:12 – Antibiotics in bronchiolitis  05:52 – Stewardship initiatives  07:12 – Vitamin D in prevention  08:21 – Viral point-of-care diagnostics 

QUICK TIP THURSDAY: Rosemary (the plant) or esesential oil is amazing for healthy hair, brain function and focus, healthy digestion and feelings of knowledge and transition. Make this roller ball today for focus: 5 drops rosemary 5 drops lemon 5 drops peppermint  Top with fractionated coconut oil Join our FACEBOOK COMMUNITY for more support and encouragement to refill daily with faith, self care, health, wellness and essential oil education! Follow Kari on Insta JOIN ME IN THE FASTER WAY TO FAT LOSS PROGRAM with my coach Lynzi! Create Your Custom Essential Oil Kit  Get my non toxic products here: https://doterra.me/n2pgTr Email hello@thewellteam.com Schedule a free 30 minute consult for potential coaching with Kari here   VISIT www.THEWELLTEAM.COM for all coaching programs, blog and essential oil education! FREEBIES: FREE:PEACEFUL HOME PLAN   2 minute wellness routine   FREE: 30 day Bible Reading Plan

This podcast is sponsored by YARAL Pharma.  In this episode, we are focusing on the management of hypothyroidism -- a treatable, but not curable condition – and will explore unique challenges for patients with hypothyroidism in long-term care – from tolerability and formulation considerations to consistent dosing and patient needs. Dr. Tamara Ruggles is not affiliated with YARAL Pharma. All views and opinions regarding hypothyroidism are solely her own and are not attributable to YARAL or the Pharmacy Podcast Network. IMPORTANT SAFETY INFORMATION for levothyroxine sodium capsules INDICATION AND USAGE Levothyroxine sodium capsules are L-thyroxine (T4) indicated for adults and pediatric patients 6 years and older with: Hypothyroidism - As replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression - As an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well differentiated thyroid cancer Limitations of Use: Levothyroxine sodium capsules are not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients as there are no clinical benefits and overtreatment with Levothyroxine sodium capsules may induce hyperthyroidism. Levothyroxine sodium capsules are not indicated for treatment of transient hypothyroidism during the recovery phase of subacute thyroiditis WARNING: NOT FOR THE TREATMENT OF OBESITY OR FOR WEIGHT LOSS Thyroid hormones, including levothyroxine sodium capsules, either alone or with other therapeutic agents, should not be used for the treatment of obesity or for weight loss. In euthyroid patients, doses within the range of daily hormonal requirements are ineffective for weight reduction. Larger doses may produce serious or even life-threatening manifestations of toxicity, particularly when given in association with sympathomimetic amines such as those used for their anorectic effects. Contraindications Uncorrected adrenal insufficiency Warnings and Precautions Cardiac adverse reactions in the elderly and in patients with underlying cardiovascular disease: Initiate Levothyroxine sodium capsules at less than the full replacement dose because of the increased risk of cardiac adverse reactions, including atrial fibrillation Myxedema coma: Do not use oral thyroid hormone drug products to treat myxedema coma Acute adrenal crisis in patients with concomitant adrenal insufficiency: Treat with replacement glucocorticoids prior to initiation of levothyroxine sodium capsules treatment Prevention of hyperthyroidism or incomplete treatment of hypothyroidism: Proper dose titration and careful monitoring is critical to prevent the persistence of hypothyroidism or the development of hyperthyroidism Worsening of diabetic control: Therapy in patients with diabetes mellitus may worsen glycemic control and result in increased antidiabetic agent or insulin requirements. Carefully monitor glycemic control after starting, changing, or discontinuing thyroid hormone therapy Decreased bone mineral density associated with thyroid hormone over-replacement: Over-replacement can increase bone reabsorption and decrease bone mineral density. Give the lowest effective dose Adverse Reactions Common adverse reactions with levothyroxine therapy are primarily those of hyperthyroidism due to therapeutic overdosage. They include the following: General: fatigue, increased appetite, weight loss, heat intolerance, fever, excessive sweating Central Nervous System: headache, hyperactivity, nervousness, anxiety, irritability, emotional ability, insomnia Musculoskeletal: tremors, muscle weakness Cardiovascular: palpitations, tachycardia, arrythmias, increased pulse and blood pressure, heart failure, angina, myocardial infarction, cardiac arrest Respiratory: dyspnea Gastrointestinal (GI): diarrhea, vomiting, abdominal cramps, elevations in liver function tests Dermatologic: hair loss, flushing Endocrine: decreased bone mineral density Reproductive: menstrual irregularities, impaired fertility Adverse Reactions in Children Pseudotumor cerebri and slipped capital femoral epiphysis have been reported in children receiving levothyroxine therapy. Overtreatment may result in craniosynostosis in infants and premature closure of the epiphyses in children with resultant compromised adult height. Seizures have been reported rarely with the institution of levothyroxine therapy. Hypersensitivity Reactions Hypersensitivity reactions to inactive ingredients (in this product or other levothyroxine products) have occurred in patients treated with thyroid hormone products. These include urticaria, pruritis, skin rash, flushing, angioedema, various GI symptoms (abdominal pain, nausea, vomiting and diarrhea), fever, arthralgia, serum sickness and wheezing. Hypersensitivity to levothyroxine itself is not known to occur. Drug Interactions: Many drugs and some foods can exert effects on thyroid hormone pharmacokinetics (e.g., absorption, synthesis, secretion, catabolism, protein binding, and target tissue response) and may alter the therapeutic response to Levothyroxine sodium capsules. Administer at least 4 hours before or after drugs that are known to interfere with absorption. See full prescribing information for drugs that affect thyroid hormone pharmacokinetics and metabolism. To report SUSPECTED ADVERSE REACTIONS, contact Yaral Pharma Inc. at 1-866-218-9009, or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. For Full Prescribing Information, including Boxed Warning, go to www.yaralpharma.com/levothyroxine-pi.

It's respiratory virus season again, and experts say to look out for the flu, COVID-19 and RSV. Infectious diseases specialist Dr. Allison McGeer explains what the data shows about how severe this year might be, as well as how Canadians can protect themselves.For transcripts of The Dose, please visit: lnk.to/dose-transcripts. Transcripts of each episode will be made available by the next workday. For more episodes of this podcast, click this link.Fill out our listener survey here. We appreciate your input!

Send us a textAntenatal Corticosteroid in Twin-Pregnant Women at Risk of Late Preterm Delivery: A Randomized Clinical Trial.Lee SM, Park HS, Choi SR, Lee J, Kim HJ, Park JY, Oh KJ, Cho GJ, Oh MJ, Chung JH, Kim SM, Kim BJ, Kim SY, Hong S, Jung YM, Lee SJ, Seong JS, Kim H, Oh S, Lee J, Jin YR, Kim JH, Cho HY, Park CW, Park JS, Jun JK.JAMA Pediatr. 2025 Sep 22:e253284. doi: 10.1001/jamapediatrics.2025.3284. Online ahead of print.PMID: 40982289Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Welcome to the Hot Topics podcast from NB Medical with Dr Neal Tucker! In this episode, we talk about some real research rather than stuff made up by over-tanned heads of state. Three papers. First, can researchers fill the gap on whether anti-inflammatory reliever therapy is best for mild asthma? Second, how effective are SCAN pathways for suspected cancer in patients with non-specific symptoms who don't meet site-specific referral criteria, and what lessons can we learn from years of referrals?Third, how do the numbers of licensed GPs differ from actual GPs working, and how does this all compare to what's happening with hospital consultants?ReferencesLancet AIR for kids asthmaLancet Primary Care SCAN referrals  BMJ Trends in practising GPswww.nbmedical.com/podcast

The state sees history-making job numbers for August despite the unemployment rate remaining steady. We take a closer look.Then, the Southern Poverty Law Center begins an annual tour this time to explain the impact of the Big Beautiful bill on Mississippians.Plus, it's the time of year that healthcare providers recommend folks be vaccinated to prevent the respiratory illness likely to spread during the winter months. Hosted on Acast. See acast.com/privacy for more information.

Stephan von Düring, MD, and Eddy Fan, MD, PhD, join CHEST® Journal Podcast Moderator Matt Siuba, DO, MS, to discuss their research into the association between mechanical power within the first 24 hours and ICU mortality in adult patients with acute hypoxemic respiratory failure who are mechanically ventilated.  DOI: 10.1016/j.chest.2025.03.012 Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers' opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine. 

In this episode of The Nurse Practitioner Podcast, Julia Rogers, DNP, APRN, CNS, FNP-BC, FAANP and Douglas Mazurek, MD discuss differentiating and treating respiratory illnesses during cold season.

Dr. Sean O'Leary joins host Dr. Edith Bracho-Sanchez to break down what parents need to know about respiratory virus season.  They explore the risks of RSV, influenza and Covid-19, and share tips for keeping babies and kids healthy. They also highlight trusted sources for evidence-based immunization schedules and how Florida's recent rollback of childhood vaccine requirements might impact community immunity and public health. For resources go to healthychildren.org/podcast.

On this episode learn about the two parts to the respiratory system and how they help you naturally fight off bad things. Hunt4Wellness is the show that helps you live your best life through mind, body & Spirit. www.Hunt4Wellness.com  

Lionel challenges official narratives, focusing on the critical difference between correlation and cause across major news stories. Topics covered include skepticism toward claims linking Tylenol to autism, the motives behind alleged radicalization like Tyler Robinson, and the impact of tech giant content policing on free speech. Lionel explores deep concerns over America losing its identity and culture, featuring listener calls debating the rise of Sharia law. Learn more about your ad choices. Visit megaphone.fm/adchoices

Is that penicillin or amoxicillin allergy real? Probably not. In this episode, we explore how to assess risk, talk to parents, and refer for delabeling. You'll also learn what happens in the allergy clinic, why the label matters, and how to be a better antimicrobial steward. Learning Objectives Describe the mechanisms and clinical manifestations of immediate and delayed hypersensitivity reactions to penicillin, including diagnostic criteria and risk stratification tools such as the PEN-FAST score. Differentiate between low-, moderate-, and high-risk penicillin allergy histories in pediatric patients and identify appropriate candidates for direct oral challenge or allergy referral based on current evidence and guidelines. Formulate an evidence-based approach for evaluating and counseling families in the Emergency Department about reported penicillin allergies, including when to recommend outpatient referral for formal delabeling. Connect with Brad Sobolewski PEMBlog: PEMBlog.com Blue Sky: @bradsobo X (Twitter): @PEMTweets Instagram: Brad Sobolewski References Khan DA, Banerji A, Blumenthal KG, et al. Drug Allergy: A 2022 Practice Parameter Update. J Allergy Clin Immunol. 2022;150(6):1333-1393. doi:10.1016/j.jaci.2022.08.028 Moral L, Toral T, Muñoz C, et al. Direct Oral Challenge for Immediate and Non-Immediate Beta-Lactam Allergy in Children. Pediatr Allergy Immunol. 2024;35(3):e14096. doi:10.1111/pai.14096 Castells M, Khan DA, Phillips EJ. Penicillin Allergy. N Engl J Med. 2019;381(24):2338-2351. doi:10.1056/NEJMra1807761 Shenoy ES, Macy E, Rowe T, Blumenthal KG. Evaluation and Management of Penicillin Allergy: A Review.JAMA. 2019;321(2):188–199. doi:10.1001/jama.2018.19283 Transcript Note: This transcript was partially completed with the use of the Descript AI and the Chat GPT 5 AI  Welcome to PEM Currents, the Pediatric Emergency Medicine podcast. As always, I'm your host, Brad Sobolewski, and today we are taking on a label that's misleading, persistent. Far too common penicillin allergy, it's often based on incomplete or inaccurate information, and it may end up limiting safe and effective treatment, especially for the kids that we see in the emergency department. I think you've all seen a patient where you're like. I don't think this kid's really allergic to amoxicillin, but what do you do about it? In this episode, we're gonna break down the evidence, walk through what actually happens during de labeling and dedicated allergy clinics. Highlight some validated tools like the pen FAST score, which I'd never heard of before. Preparing for this episode and discuss the current and future role of ED based penicillin allergy testing. Okay, so about 10% of patients carry a penicillin allergy label, but more than 90% are not truly allergic. And this label can be really problematic in kids. It limits first line treatment choices like amoxicillin, otitis media, or penicillin for strep throat, and instead. Kids get prescribed second line agents that are less effective, broader spectrum, maybe more toxic or poorly tolerated and associated with a higher risk of antimicrobial resistance. So it's not just an EMR checkbox, it's a label with some real clinical consequences. And it's one, we have a role in removing. And so let's understand what allergy really means. And most patients with a reported penicillin allergy, especially kids, aren't true allergies in the immunologic sense. Common misinterpretations include a delayed rash, a maculopapular, or viral exum, or benign, delayed hypersensitivity, side effects, nausea, vomiting, and diarrhea. And unverified childhood reactions that are undocumented and nonspecific. Most of these are not true allergies. Only a very small subset of patients actually have IgE mediated hypersensitivity, such as urticaria, angioedema, wheezing, and anaphylaxis. These are super rare, and even then they may resolve over time without treatment. If a parent or sibling has a history of a penicillin allergy, remember that patient might actually not be allergic, and that is certainly not a reason to label a child as allergic just because one of their first degree relatives has an allergy. So right now, in 2025, as I'm recording this episode, there are clinics like the Pats Clinic or the Penicillin Allergy Testing Services at Cincinnati Children's and in a lot of our peer institutions that are at the forefront of modern de labeling. Their approach reflects the standard of care as outlined by the. Quad ai or the American Academy of Allergy, asthma and Immunology and supported by large trials like Palace. And you know, you have a great trial if you have a great acronym. So here's what happens step by step. So first you stratify the risk. How likely is this to be a true allergy? And that's where a tool like the pen fast comes. And so pen fast scores, a decision rule developed to help assess the likelihood of a true penicillin allergy based on the patient's history. The pen in pen fast is whether or not the patient has a self-reported history of penicillin allergy. They get two points if the reaction occurred in the past five years. Two points if the reaction is anaphylaxis or angioedema. One point if the reaction required treatment, and one point if the reaction was not due to testing. And so you can get a total score of. Up to six points. If you have a score of less than three. This is a low risk patient and they can be eligible for direct oral challenge. A score greater than three means they're higher risk and they may require skin testing. First validation studies show that the PEN FFA score of less than three had a negative predictive value of 96.3%. Meaning a very, very low chance of a true allergy. And this tool has been studied more extensively in adults, but pediatric specific adaptations are emerging, and they do inform current allergy clinic protocols. But I would not use this score in the emergency department just to give a kid a dose of amoxicillin. So. For low risk patients, a pen fast score of less than three or equivalent clinical judgment clinics proceed with direct oral challenge with no skin testing required. The protocol is they administer one dose of oral amoxicillin and they observe for 62 120 minutes monitoring for signs of reaction Urticaria. Respiratory symptoms or GI upset. This approach is safe and effective. There was a trial called Palace back in 2022, which validated this in over 300 children. In adolescents. There were no serious events that occurred. De labeling was successful in greater than 95% of patients. And skin tested added no benefit in low risk patients. So if the child tolerates this dose, then you can remove that allergy immediately from the chart. Parents and primary care doctors will receive a summary letter noting that the challenge was successful and that there's new guidance. Children and families are told they can safely receive all penicillins going forward. And providers are encouraged to document this clearly in the allergy section of the EMR. So you're wondering, can we actually do this in the emergency department? Technically, yes, you can do what you want, but practically we're not quite there yet. So we'd need clearer risk stratification tools like the Pen fast, a safe place for monitoring, post challenge, clinical pathways and documentation support. You know, a clear way to update EMR allergy labels across the board and involvement or allergy or infectious disease oversight. But it's pretty enticing, right? See a kid you diagnose otitis media. You think that their penicillin allergy is wrong, you just give 'em a dose of amox and watch 'em for an hour. That seems like a pretty cool thing that we might be able to do. So some centers, especially in Canada and Australia, do have some protocols for ED or inpatient based de labeling, but they rely on that structured implementation. So until then, our role in the pediatric emergency department is to identify low risk patients, avoid over document. Unconfirmed reactions and refer to allergy ideally to a clinic like the pets. So who should be referred and good candidates Include a child with a rash only, especially one that's remote over a year ago. Isolated GI symptoms. Parents unsure of the details at all. No history of anaphylaxis wheezing her hives, and no recent serious cutaneous reactions. I would avoid referring and presume that this allergy is true. If they've had recent anaphylaxis, they've had something like Stevens Johnson syndrome dress, or toxic epidermolysis necrosis. Fortunately, those are very, very rare with penicillins and there's a need for penicillin during the ED visit without allergy backup. So even though we don't have an ED based protocol yet. De labeling amoxicillin or penicillin allergy can start with good questions in the emergency department. So here's one way to talk to patients and families. You can say, thanks for letting me know about the amoxicillin allergy. Can I ask you a few questions to better understand what happened? This is gonna help us decide the safest and most effective treatment for your child today, and then possibly go through a process to remove a label for this allergy that might not be accurate. You wanna ask good, open-ended questions. What exactly happened when your child took penicillin or amoxicillin? You know, look for rash, hives, swelling, trouble breathing, or anaphylaxis. Many families just say, allergic, when the reaction was just GI upset, diarrhea or vomiting, which is not an allergy. How old was your child when this happened? Reactions that occurred before age of three are more likely to be falsely attributed. How soon after taking the medicine did the reaction start? Less than one hour is an immediate reaction, but one hour to days later is delayed. Usually mild and probably not a true allergy. Did they have a fever, cold or virus at that time? Viral rashes are often misattributed to antibiotics, and we shouldn't be treating viruses with antibiotics anyway, so get good at looking at ears and know what you're seeing. And have they taken similar antibiotics since then? Like. Different penicillins, Augmentin, or cephalexin. So if they said that they were allergic to amoxicillin, but then somehow tolerated Augmentin. They're not allergic. If a patient had rash only, but no hive swelling or difficulty breathing, no reaction within the first hour. It occurred more than five years ago or before the kid was three. And especially if they tolerated beta-lactam antibiotics. Since then, they're a great candidate for de labeling and I would refer that kid to the allergy clinic. Generally, they can get them in pretty darn quick. Alright, we're gonna wrap up this episode. Most kids labeled penicillin allergic or amoxicillin allergic, or not actually allergic to the medication. There are some scores like pen fasts that are validated tools to assess risk and support de labeling. Direct oral challenge for most patients is safe, efficient, and increasingly the standard of care. There are allergy clinics like the Pats at Cincinnati Children's that can dela children in a single visit with oral challenges alone, needing no skin testing, and emergency departments can play a key role in identifying and referring these patients and possibly de labeling ourselves in the future. Well, that's all for this episode on Penicillin Allergy. I hope you learn something new, especially how to assess whether an allergy label is real, how to ask the right questions and when to refer to an allergy testing clinic. If you have feedback, send it my way. Email, comment on the blog, a message on social media. I always appreciate hearing from you all, and if you like this episode, please leave a review on your favorite podcast app. Really helps more people find the show and that's great 'cause I like to teach people stuff. Thanks for listening for PEM Currents, the Pediatric Emergency Medicine podcast. This has been Brad Sobolewski. See you next time.

https://jo.my/le58ll Respiratory Protection & Airborne Hazards: Keep It Clean, Keep It Safe Let's talk about something you don't see—but definitely feel. Airborne hazards. Dust. Fumes. Mists. Vapors. The stuff that hangs in the air and messes with your lungs if you're not protected. That's where your respirator comes in. But a respirator's only as good as the condition it's in. Week 4 is all about Cleaning, Storage, and Responsibility when it comes to respiratory protection. We're not just throwing on a mask and calling it good. You've got to take care of your gear if you want it to take care of you. Here are a few things to lock in when dealing with respirators on the floor: 1. Clean it after each use.  Sweat, dust, oils—your respirator collects a lot during the day. Always clean it according to the manufacturer's instructions. Use mild soap and warm water. Skip the harsh chemicals. They'll damage the material and reduce protection. 2. Store it the right way.  Don't toss it in your locker or throw it on a dusty shelf—store respirators in a sealed container or bag. Keep them dry, away from direct sunlight, chemicals, or anything that might cause contamination or damage. 3. Replace filters regularly.  You'll know when it's time. Breathing starts to feel harder, or you're catching more odors than usual. Don't wait until you're gasping—swap filters out based on the schedule your facility recommends, or sooner if needed. 4. Check your gear—every time.  Before each use, do a quick check. Look for cracks, dry rot, worn straps, or missing valves. If something feels off—it probably is. Please don't use it. 5. Take foul gear out of the game.  If a respirator is damaged, expired, or in any way—tag it, report it, and remove it from service. No exceptions. As always, these are potential tips. Please be sure to follow the rules and regulations of your specific facility. Respiratory protection isn't just about what you wear—it's how you care for it. A clean, well-maintained respirator means you're getting the whole level of protection every time you put it on. It means fewer health risks and more time getting the job done right. A strong Safety Culture depends on personal responsibility. That means keeping your gear clean, storing it safely, and replacing it when needed. And knowing that your health depends on the steps you take before your shift even starts. Thank you for being part of another episode of Warehouse Safety Tips. Until we meet next time – have a great week, and STAY SAFE! #Safety #SafetyCulture #RespiratoryProtection #PPE #AirborneHazards #SafetyFirst #CleanYourGear 

It's The Ranch It Up Radio Show! Join Jeff Tigger Erhardt, Rebecca Wanner AKA BEC and their crew as they go through everything about maximizing your potential feeder cattle profits from genetics to herd health, to calf uniformity to buyer relations.  Plus market reports and where to find your next show steer Or heifer and a whole lot more on this all new episode of The Ranch It Up Radio Show. Be sure to subscribe on your favorite podcasting app or on the Ranch It Up Radio Show YouTube Channel. Feeder Cattle Buyers Paying Premiums For Properly Vaccinated Calves Through PrimeVAC by Merck Animal Health PrimeVAC preconditioning programs by Merck Animal Health offer a comprehensive mix of proven products and protocols that boost calf health, performance and marketability. Veterinarian-approved PrimeVAC certifications help build credibility and provide value-added premiums for your calves on sale day. With different options available, select the PrimeVAC program that works best for your operation's goals. PrimeVAC focuses on three essential areas of protection: Respiratory viruses and bacteria Clostridial disease Internal parasites PrimeVAC also includes elective implant options. PrimeVAC Certified Calves On The VAC45 Protocol Added $48.39 More Per Head, Compared To Those Of VAC24 Featured Experts in the Cattle Industry Tim Parks, DVM – Merck Animal Health https://www.merck-animal-health-usa.com/ Follow on Facebook: @MerckAnimalHealth Mark Vanzee – Livestock, Equine, & Auction Time Expert https://www.auctiontime.com/ https://www.livestockmarket.com/ https://www.equinemarket.com/ Follow on Facebook: @LivestockMkt | @EquineMkt | @AuctionTime Kirk Donsbach – Financial Analyst at StoneX https://www.stonex.com/ Follow on Facebook: @StoneXGroupInc Shaye Wanner – Host of Casual Cattle Conversation https://www.casualcattleconversations.com/ Follow on Facebook: @cattleconvos Contact Us with Questions or Concerns Have questions or feedback? Feel free to reach out via: Call/Text: 707-RANCH20 or 707-726-2420 Email: RanchItUpShow@gmail.com Follow us: Facebook/Instagram: @RanchItUpShow YouTube: Subscribe to Ranch It Up Channel: https://www.youtube.com/c/RanchItUp Catch all episodes of the Ranch It Up Podcast available on all major podcasting platforms. Discover the Heart of Rural America with Tigger & BEC Ranching, farming, and the Western lifestyle are at the heart of everything we do. Tigger & BEC bring you exclusive insights from the world of working ranches, cattle farming, and sustainable beef production. Learn more about Jeff 'Tigger' Erhardt & Rebecca Wanner (BEC) and their mission to promote the Western way of life at Tigger and BEC. https://tiggerandbec.com/ Industry References, Partners and Resources For additional information on industry trends, products, and services, check out these trusted resources: Allied Genetic Resources: https://alliedgeneticresources.com/ American Gelbvieh Association: https://gelbvieh.org/ Axiota Animal Health: https://axiota.com/multimin-campaign-landing-page/ Imogene Ingredients: https://www.imogeneingredients.com/ Jorgensen Land & Cattle: https://jorgensenfarms.com/ Medora Boot: https://medoraboot.com/ RFD-TV: https://www.rfdtv.com/ Rural Radio Network: https://www.ruralradio147.com/ Superior Livestock Auctions: https://superiorlivestock.com/ Transova Genetics: https://transova.com/ Westway Feed Products: https://westwayfeed.com/ Wrangler: https://www.wrangler.com/ Wulf Cattle: https://www.wulfcattle.com/

What happens when we get breathwork wrong — and how can we use it wisely for health and balance?In Part 2, Patrick and Hannah dig deeper into the nuances of breath practice, from hyperventilation methods to breath holds, and the role of carbon dioxide in nervous system regulation. Patrick explains where breathwork can heal, where it can harm, and how yoga teachers can cue breathing safely and effectively.This half of the conversation is packed with practical takeaways, cautions, and inspiration to bring into both your teaching and everyday life.We explore:Why some popular hyperventilation practices may carry real risksBreath holds: stress vs relaxation, and how to use them wiselyThe role of CO₂ in blood flow, oxygen delivery, and calmBreathing differences in women across the monthly cycleWhy breathing is the most powerful free tool for stress, sleep, and focusAbout PatrickTo date, Patrick has worked with some of the top athletes in the world across a variety of sports including tennis, cycling, weight lifting, American Football, MMA and track and field. Patrick's professional memberships include Fellow of The Royal Society of Biology, and Chairman of Buteyko Professionals International (BPI).A TEDx speaker, Patrick's work has touched the lives of thousands and more worldwide. His work has been published by leading publishing houses including Harper Collins (UK), William Morrow Press (USA), Red Wheel Weiser (USA), Sperling & Kupfer (Italy), Kanki Publishing Inc. (Japan). Journal publications include the American Journal of Respiratory and Critical Care Medicine, The Journal of the American Orthodontic Society and Clinical Otolaryngology.Patrick's book, ⁠⁠The Oxygen Advantage⁠⁠ is an extension of this work, combining simulation of high-altitude training and specifically-formulated exercises which empower athletes to improve their sports performance safely, legally and at no cost. For the first time, athletes are afforded a reliable and accurate means to measure their progress using the Body Oxygen Level Test, enabling them to address poor breathing habits; understand in simple terms how oxygen is released to working muscles; and to practice breath hold exercises that naturally increase aerobic and anaerobic capacity.The team at Oxygen Advantage have granted listeners to this podcast an incredible 20% off their ⁠Breathing For Yoga Instructor training Course⁠ - use code ALBA20 at checkout!About Alba Yoga Academy⁠⁠Learn more with Alba Yoga Academy⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Learn more about our Yoga Teacher Training here.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Watch our extensive library of YouTube videos.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Follow Hannah on Instagram.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Follow Celest on Instagram ⁠⁠⁠⁠⁠

Vidcast:  https://www.instagram.com/p/DOwe9yfDnI2/Azelastine nasal spray, marketed as Astepro but also available as a generic, can reduce your chances of developing a CoVid infection by a factor of 3 and cut your chances of developing a common cold by a factor of 3.5.  German researchers at Saarland University recently published their double-blind, placebo-controlled study of 450 participants in the JAMA Internal Medicine Journal.Half the subjects received azelastine 0.1% nasal spray three times a day for 56 days. The control subjects used  a similarly-appearing but inactive nasal spray.  Respiratory infections were confirmed using PCR analyses.  The results showed that only 2.2% of the azelestine sprayers developed CoVid compared with 6.7% of controls.  Only 1.8% of azelestine sprayers developed rhinovirus infections compared with 6.3% of controls.Generic azelastine spray is a prescription medication.  Astepro Spray, the same medication, is available over-the-counter.  If you think you might benefit, give it a try.https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2838335#azelastine #astepro #allergy #CoVid #rhinovirus #commoncold

Dr. Susan Kansagra, Chief Medical Officer at ASTHO, discusses updates to federal health initiatives that continue to impact public health agencies, including the latest report from the Make America Health Again Commission and recent activity regarding vaccines; Tiffany Day, Public Health Specialist with the Henry County Health Department in Ohio, previews what she'll discuss as a speaker during ASTHO's Succession Planning webinar session tomorrow, and highlights how succession planning can enhance the existing public health workforce; it's Telehealth Awareness Week and ASTHO's resource page has everything your department needs to expand its telehealth initiatives; and applications are now open for the second cohort of the Leadership Exchange for Adolescent Health Promotion Plus Community of Practice, which can help health agencies advance health education.  U.S. Dept of HHS: MAHA Commission Unveils Sweeping Strategy to Make Our Children Healthy Again U.S. Dept of HHS: CDC's Advisory Committee on Immunization Practices to Meet September 18-19 ASTHO Blog: Levers for Preventing Chronic Disease That Intersect with Key MAHA Report Themes ASTHO Web Page: Telehealth ASTHO Webinar: Succession Planning Part 2 of 3: Laying the Groundwork ASTHO Web Page: Leadership Exchange for Adolescent Health Promotion Plus (LEAHP+) Community of Practice Cohort 2  

In this important episode of Transmission Interrupted, host Jill Morgan is joined by a distinguished panel of experts to provide a comprehensive update on respiratory illness trends for the 2025 season. Dr. Ryan Maves (infectious diseases and critical care medicine, Wake Forest University), Dr. Kari Simonson (pediatric infectious diseases, University of Nebraska Medical Center), and Dr. John Horton (clinical affairs, gynecology and obstetrics, Emory University) share the latest data and evidence-based recommendations for healthcare providers and the public.The discussion covers the full spectrum of respiratory viruses currently impacting our communities, including influenza, RSV, COVID-19, and pertussis. The panel addresses the unique risks facing infants, children, pregnant individuals, older adults, and those with underlying health conditions. Listeners will gain valuable insight into current vaccine guidance, the role of updated testing strategies, and protective measures that go beyond vaccination—such as proper mask use, respiratory and hand hygiene, and the importance of source control and eye protection.This episode offers practical guidance for both healthcare workers and the public as we enter another busy respiratory virus season. Drawing on real-world experience and the latest research, our guests emphasize steps we can all take to reduce transmission, protect vulnerable populations, and maintain safety in both clinical and home settings.GuestsJohn Patrick Horton, MD, MBAVice Chair of Clinical Affairs for Gynecology and Obstetrics Emory UniversityDr. John Horton is the Vice Chair of Clinical Affairs for Emory University's Department of Gynecology and Obstetrics. He also serves as Emory Healthcare's Division Director for General Gynecology and Obstetrics, and Interim Operations Director for the Gynecologic Specialties Division. Additionally, Dr. Horton is the Director of the Obstetric Rapid Response Team at Emory Healthcare and is Associate Professor at the Emory University School of Medicine Department of Gynecology and Obstetrics. Ryan Maves, MD, FCCM, FCCP, FIDSAProfessor in Infectious Disease and Critical Care MedicineOffice of Global HealthWake Forest UniversityDr. Ryan Maves is a Professor of Medicine at the Wake Forest University School of Medicine in Winston-Salem, North Carolina, where he serves as medical director of transplant infectious diseases and as a faculty intensivist at North Carolina Baptist Hospital. A graduate of the University of Washington School of Medicine, he entered active duty in the U.S. Navy in 1999. He completed his residency in internal medicine and fellowships infectious diseases and critical care medicine at Naval Medical Center San Diego. During his military service, he served as the flight surgeon for Carrier Air Wing SEVENTEEN embarked onboard the USS George Washington (CVN-73), at the Naval Medical Research Unit No. 6 in Lima, Peru, conducting preclinical and clinical studies in antimicrobial drug resistance and vaccine development, as director of medical services at the NATO Role 3 Multinational Medical Unit at Kandahar Airfield, Afghanistan, and as ID division chief and fellowship director in San Diego. He retired from active duty in 2021 and joined the faculty at Wake Forest. He is the chair of the ABIM Critical Care Medicine Examination Board, co-chair of the SCCM Congress Program Committee, and Chair-Elect of the Chest Infections and Disaster Response Network in CHEST, as well as deputy editor for outreach for the journal CHEST and contributing editor for Critical Care Explorations. He is an author of over 150 scientific manuscripts, 15 textbook chapters, and 100 conference abstracts and invited lectures. He lives in Winston-Salem with his wife, Robin, whom he met in the traditional manner (in the ICU, next to a...

https://jo.my/uxkilh Respiratory Protection & Airborne Hazards: Fit Testing and Medical Evaluations Breathing is something we don't think about—until it gets hard to do. In a warehouse environment, airborne hazards like dust, fumes, or chemical vapors can put workers at risk quickly. That's where respiratory protection comes in. But having a respirator isn't enough. It needs to fit correctly, be appropriately used, and, most importantly, be safe for you to wear. One of the top priorities of a solid Safety Culture is making sure every team member is not only equipped—but cleared and trained—to use personal protective equipment (PPE) correctly. This week, we're focusing on two of the most critical pieces of that process: Fit Testing and Medical Evaluations. A mask that doesn't seal is a mask that doesn't protect. And a worker who's not cleared to wear one can face serious health risks. So let's talk through what to watch for. Here are a few things to keep in mind when it comes to fit testing and medical evaluations: Get fit tested every year. No exceptions. Also, if you lose or gain significant weight, undergo dental surgery, or change the model of your respirator, you'll need a new fit test. Faces change. So does fit. Keep facial hair trimmed. A beard, stubble, or even long sideburns can break the seal on a tight-fitting respirator. That means it's not doing its job. Clean-shaven is the safest way to go. Medical clearance comes first. Before someone uses a respirator—even once—they need to complete a medical evaluation. It's not red tape. It's a health check to make sure their lungs and heart can handle the added strain. Check the seal every time. Positive and negative seal checks take seconds. Cover the valves and breathe in or out. If you feel air leaking, something's off. Stop and fix it before starting work. Speak up if something feels wrong. If you're short of breath, lightheaded, or your respirator feels loose or broken—report it. Right away. This stuff isn't minor. Don't wait and see. As always, these are potential tips. Please be sure to follow the rules and regulations of your specific facility. Respirators protect you from what you can't see—dust, vapors, airborne contaminants. But only if they're used right. That starts with knowing they fit, knowing you're cleared to wear them, and making checks a habit every single time. A lot of injuries are visible—cuts, falls, burns. Respiratory issues sneak up. Sometimes the damage is done before you even realize it. Fit testing and medical evaluations are your front-line defense. Respect the process. Trust the equipment. And if something's off—say something. Thank you for being part of another episode of Warehouse Safety Tips. Until we meet next time – have a great week, and STAY SAFE! #Safety #SafetyCulture #RespiratorSafety #FitTesting #PPEAwareness #BreatheSafe #AirQuality #AirborneHazards

Fins, Fur and Feathers: Voles Storage Tank Safety in Agriculture Awarding McCarty Family Farms   00:01:05 – Fins, Fur and Feathers: Voles: K-State wildlife specialist Drew Ricketts and fisheries and aquatics Extension specialist Joe Gerken start the show as they discuss voles and what to do if you see the rodent in your yard. Fins, Fur, and Feathers wildlife.k-state.edu   00:12:05 – Storage Tank Safety in Agriculture: Continuing the show is Mitch Ricketts, professor of agricultural safety and health at K-State, as he explains the safety concerns and precautions for storage tanks on agricultural operations. Protecting Yourself from Respiratory Hazards in Agriculture   00:23:05 – Awarding McCarty Family Farms: K-State dairy specialist Mike Brouk ends the show taking a closer look at McCarty Family Farms, a fourth-generation dairy farm family, that will be recognized as the 2025 Dairy Producers of the Year at the World Dairy Expo at an awards banquet on October 1.      Send comments, questions or requests for copies of past programs to ksrenews@ksu.edu.   Agriculture Today is a daily program featuring Kansas State University agricultural specialists and other experts examining ag issues facing Kansas and the nation. It is hosted by Shelby Varner and distributed to radio stations throughout Kansas and as a daily podcast.   K‑State Research and Extension is a short name for the Kansas State University Agricultural Experiment Station and Cooperative Extension Service, a program designed to generate and distribute useful knowledge for the well‑being of Kansans. Supported by county, state, federal and private funds, the program has county Extension offices, experiment fields, area Extension offices and regional research centers statewide. Its headquarters is on the K‑State campus in Manhattan

Respiratory syncytial virus vaccination in pregnancy (1:30), vasectomy (3:40), donanemab in Alzheimer disease (7:20), multicancer early detection (12:20), autism spectrum disorder (13:50), and acute pancreatitis (17:10).

Send us a textRespiratory Targets Associated With Lung Aeration During Delivery Room Resuscitation of Preterm Neonates. Rub DM, Hsu JY, Weinberg DD, Felix M, Nadkarni VM, Te Pas AB, Kuypers KLAM, Davis PG, Ratcliffe SJ, Kirpalani HM, Foglia EE.JAMA Pediatr. 2025 Aug 11:e252521. doi: 10.1001/jamapediatrics.2025.2521. Online ahead of print.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

What if the way you're breathing is the very thing holding you back?In this first half of our conversation with world-renowned breathing expert Patrick McKeown, we dive into the surprising science of functional breathing and its impact on health, focus, and yoga. Patrick shares his personal journey with asthma and poor sleep, and how discovering the Buteyko method changed his life.You'll learn why “taking a deep breath” isn't always the best advice, and how subtle changes in the way you breathe can influence everything from your concentration to your recovery.We explore:Patrick's story of transforming his asthma and sleep through breathingWhy nasal breathing matters so much more than you thinkThe myth of “bigger breaths = more oxygen” and what science really showsThe lost history of yoga breathing, and why subtlety is the keyHow small adjustments in practice can boost blood flow, calm the mind, and improve performanceAbout PatrickTo date, Patrick has worked with some of the top athletes in the world across a variety of sports including tennis, cycling, weight lifting, American Football, MMA and track and field. Patrick's professional memberships include Fellow of The Royal Society of Biology, and Chairman of Buteyko Professionals International (BPI).A TEDx speaker, Patrick's work has touched the lives of thousands and more worldwide. His work has been published by leading publishing houses including Harper Collins (UK), William Morrow Press (USA), Red Wheel Weiser (USA), Sperling & Kupfer (Italy), Kanki Publishing Inc. (Japan). Journal publications include the American Journal of Respiratory and Critical Care Medicine, The Journal of the American Orthodontic Society and Clinical Otolaryngology.Patrick's book, ⁠The Oxygen Advantage⁠ is an extension of this work, combining simulation of high-altitude training and specifically-formulated exercises which empower athletes to improve their sports performance safely, legally and at no cost. For the first time, athletes are afforded a reliable and accurate means to measure their progress using the Body Oxygen Level Test, enabling them to address poor breathing habits; understand in simple terms how oxygen is released to working muscles; and to practice breath hold exercises that naturally increase aerobic and anaerobic capacity.The team at Oxygen Advantage have granted listeners to this podcast an incredible 20% off their Breathing For Yoga Instructor training Course - use code ALBA20 at checkout!About Alba Yoga Academy⁠Learn more with Alba Yoga Academy⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Learn more about our Yoga Teacher Training here.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Watch our extensive library of YouTube videos.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Follow Hannah on Instagram.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Follow Celest on Instagram ⁠⁠⁠⁠⁠

Husband-and-wife team William Firth Wells and Mildred Weeks Wells conducted research that had the potential to make a big difference in the safety of indoor air. But it didn’t really have a significant impact on public health. Research: Associated Press. “Super-Oyster Is On its Way to Dinner Table Bigger and Better Bivalve Sports Pedigree.” 3/13/1927. https://www.loc.gov/resource/sn84020064/1927-03-13/ed-1/?sp=14 “Brought Back to Texas.” The Houston Semi-Weekly Post. 12/26/1889. https://www.newspapers.com/image/1196039760/ Decatur Daily Review. “Scientists Fight Flu Germs with Violet Ray.” 7/30/1936. https://www.newspapers.com/image/94335504/ Evening Star. “Scientific Trap-shooter.” 6/26/1937. https://www.loc.gov/resource/sn83045462/1937-06-26/ed-1/?sp=7&q=William+Firth+Wells&r=0.668,0.557,0.438,0.158,0 Fair, Gordon M. and William Weeks Wells. “Method and Apparatus for Preventing Infection.” U.S. Patent 2,198,867. https://ppubs.uspto.gov/api/pdf/downloadPdf/2198867 Hall, Dominic. “New Center for the History of Medicine Artifact - Wells Air Centrifuge.” Harvard Countway Library. https://countway.harvard.edu/news/new-center-history-medicine-artifact-wells-air-centrifuge “Incubator Is Now Oyster Nurse.” Washington Times. 10/1/1925. https://www.loc.gov/resource/sn84026749/1925-10-01/ed-1/?sp=12 Lewis, Carol Sutton. “Mildred Weeks Wells’s Work on Airborne Transmission Could Have Saved Many Lives—If the Scientific Establishment Listened.” Lost Women of Science Podcast. Scientific American. 5/22/2025. https://www.scientificamerican.com/article/a-public-health-researcher-and-her-engineer-husband-found-how-diseases-can/ Library and Archives Team. “William Firth Wells and Mildred Weeks Wells.” Washington College. https://www.washcoll.edu/people_departments/offices/miller-library/archives-special-collections/archives-blog/Wells%20papers.php Molenti, Megan. “The 60-Year-Old Scientific Screwup That Helped Covid Kill.” Wired. 5/13/2021. https://www.wired.com/story/the-teeny-tiny-scientific-screwup-that-helped-covid-kill/ Perkins JE, Bahlke AM, Silverman HF. Effect of Ultra-violet Irradiation of Classrooms on Spread of Measles in Large Rural Central Schools Preliminary Report. Am J Public Health Nations Health. 1947 May;37(5):529-37. PMID: 18016521; PMCID: PMC1623610. Randall, Katherine and Ewing, E. Thomas and Marr, Linsey and Jimenez, Jose and Bourouiba, Lydia, How Did We Get Here: What Are Droplets and Aerosols and How Far Do They Go? A Historical Perspective on the Transmission of Respiratory Infectious Diseases (April 15, 2021). Available at SSRN: https://ssrn.com/abstract=3829873 Riley, Richard L. “What Nobody Needs to Know About Airborne Infection.” American Journal of Respiratory and Critical Care Medicine. Volume 163, Issue 1. https://www.atsjournals.org/doi/10.1164/ajrccm.163.1.hh11-00 Simon, Clea. “Did a socially awkward scientist set back airborne disease control?” The Harvard Gazette. 3/7/2025. https://news.harvard.edu/gazette/story/2025/03/did-a-socially-awkward-scientist-set-back-airborne-disease-control/ “Texas State News.” McKinney Weekly Democrat-Gazette. 4/17/1890. https://www.newspapers.com/image/65385350/ WELLS MW, HOLLA WA. VENTILATION IN THE FLOW OF MEASLES AND CHICKENPOX THROUGH A COMMUNITY: Progress Report, Jan. 1, 1946 to June 15, 1949, Airborne Infection Study, Westchester County Department of Health. JAMA. 1950;142(17):1337–1344. doi:10.1001/jama.1950.02910350007004 WELLS MW. VENTILATION IN THE SPREAD OF CHICKENPOX AND MEASLES WITHIN SCHOOL ROOMS. JAMA. 1945;129(3):197–200. doi:10.1001/jama.1945.02860370019006 WELLS WF, WELLS MW. AIR-BORNE INFECTION. JAMA. 1936;107(21):1698–1703. doi:10.1001/jama.1936.02770470016004 WELLS WF, WELLS MW. AIR-BORNE INFECTION: SANITARY CONTROL. JAMA. 1936;107(22):1805–1809. doi:10.1001/jama.1936.02770480037010 Wells, W F, and M W Wells. “Measurement of Sanitary Ventilation.” American journal of public health and the nation's health vol. 28,3 (1938): 343-50. doi:10.2105/ajph.28.3.343 Wells, William Firth and Gordon Maskew Fair. Viability of B. coli Exposed to Ultra-Violet Radiation in Air.Science82,280-281(1935).DOI:10.1126/science.82.2125.280.b Wells, William Firth and Mildred Weeks Wells. Measurement of Sanitary Ventilation American Journal of Public Health and the Nations Health 28, 343_350, https://doi.org/10.2105/AJPH.28.3.343 Zimmer, Carl. “Air-Borne: The Hidden History of the Life We Breathe.” Dutton. 2025. See omnystudio.com/listener for privacy information.

  Ever since the world was overtaken by the COVID-19 pandemic, public health policy and vaccine policy have been front and center in the national political debate. And tragically, despite a longstanding and overwhelming consensus among public health experts across the globe about the efficacy of vaccines and their vital importance in protecting human health […]

08/31/25The Healthy Matters PodcastS04_E23 - Beyond the Common Cold:  Understanding PneumoniaWith Special Guest:  Dr. Jessica Oswald, DOPneumonia!  It's something we've all heard of - or maybe even had!  It's sometimes deadly, sometimes contagious and almost always misunderstood.  But what's going on in the body exactly?  Is it contagious?  How is it different than a bad cold or bronchitis?  And why does it start with the letter P anyway?  (sorry, we don't really have an answer for that one...)The lungs are sensitive spaces in our body and without proper care and preventative strategies, things can go sideways pretty quickly.  Thankfully on Episode 23 of our show we'll be joined by Dr. Jessica Oswald to get a baseline on these organs and what's happening when pneumonia sets in.  We'll go over who's at risk, what causes it, what can be done if you have it, and the best bets for how to dodge this pesky p-word.  And although you can't get it from having wet hair outside in the middle of Winter, Fall and Winter are peak seasons for pneumonia, so join us and get wise before they get here!We're open to your comments or ideas for future shows!Email - healthymatters@hcmed.orgCall - 612-873-TALK (8255)Get a preview of upcoming shows on social media and find out more about our show at www.healthymatters.org.

Drs. Whitney Hartlage (@whithartlage11) and Sam Windham join Dr. Ryan Moenster to discuss updates in the diagnosis and management of community-acquire pneumonia. Hear from our guests on the role of rapid diagnostic tests such as multiplex PCR and urinary antigen tests in the inpatient and outpatient setting, considerations for initiating steroids and withholding macrolides, and when to use short antibiotic durations. Listen to Breakpoints on iTunes, Overcast, Spotify, Listen Notes, Player FM, Pocket Casts, TuneIn, Blubrry, RadioPublic, or by using our RSS feed: https://sidp.pinecast.co/. Visit our website! https://breakpoints-sidp.org/ References: Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, Cooley LA, Dean NC, Fine MJ, Flanders SA, Griffin MR, Metersky ML, Musher DM, Restrepo MI, Whitney CG. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019 Oct 1;200(7):e45-e67. doi: 10.1164/rccm.201908-1581ST. PMID: 31573350; PMCID: PMC6812437. Chaudhuri D, Nei AM, Rochwerg B, Balk RA, Asehnoune K, Cadena R, Carcillo JA, Correa R, Drover K, Esper AM, Gershengorn HB, Hammond NE, Jayaprakash N, Menon K, Nazer L, Pitre T, Qasim ZA, Russell JA, Santos AP, Sarwal A, Spencer-Segal J, Tilouche N, Annane D, Pastores SM. 2024 Focused Update: Guidelines on Use of Corticosteroids in Sepsis, Acute Respiratory Distress Syndrome, and Community-Acquired Pneumonia. Crit Care Med. 2024 May 1;52(5):e219-e233. doi: 10.1097/CCM.0000000000006172. Epub 2024 Jan 19. PMID: 38240492. Odeyemi Y, Tekin A, Schanz C, Schreier D, Cole K, Gajic O, Barreto E. Comparative effectiveness of azithromycin versus doxycycline in hospitalized patients with community acquired pneumonia treated with beta-lactams: A multicenter matched cohort study. Clin Infect Dis. 2025 May 16:ciaf252. doi: 10.1093/cid/ciaf252. Epub ahead of print. PMID: 40378193. Butler AM, Nickel KB, Olsen MA, Sahrmann JM, Colvin R, Neuner E, O'Neil CA, Fraser VJ, Durkin MJ. Comparative safety of different antibiotic regimens for the treatment of outpatient community-acquired pneumonia among otherwise healthy adults. Clin Infect Dis. 2024 Oct 23:ciae519. doi: 10.1093/cid/ciae519. Epub ahead of print. PMID: 39442057; PMCID: PMC12355227. Furukawa Y, Luo Y, Funada S, Onishi A, Ostinelli E, Hamza T, Furukawa TA, Kataoka Y. Optimal duration of antibiotic treatment for community-acquired pneumonia in adults: a systematic review and duration-effect meta-analysis. BMJ Open. 2023 Mar 22;13(3):e061023. doi: 10.1136/bmjopen-2022-061023. PMID: 36948555; PMCID: PMC10040075 Schober T, Wong K, DeLisle G, et al. Clinical outcomes of rapid respiratory virus testing in emergency departments. JAMA Intern Med. 2024;184(5):528-536. Clark T, Lindsley K, Wigmosta T, et al. Rapid multiplex PCR for respiratory viruses reduces time to result and improves clinical care: results of a systematic review and meta-analysis. J Infect. 2023;86(5):462-475. May L, Robbins EM, Canchola JA, Chugh K, Tran NK. A study to assess the impact of the cobas point-of-care RT-PCR assay (SARS-CoV-2 and Influenza A/B) on patient clinical management in the emergency department of the University of California at David Medical Center. J Clin Virol. 2023:168:105597. Cartuliares MB, Rosenvinge FS, Mogensen CB, Skovsted TA, Andersen SL, Østergaard C, et al. Evaluation of point-of-care multiplex polymerase chain reaction in guiding antibiotic treatment of patients acutely admitted with suspected community-acquired pneumonia in Denmark: a multicentre randomised controlled trial. PLoS Med. 2023;20:e1004314. doi: 10.1371/ journal.pmed.1004314. Vaughn VM, Dickson RP, Horowitz JK, Flanders SA. Community-acquired pneumonia: a review. JAMA. 2024;332(15):1282-1295. Davis MR, McCreary EK, Trzebucki AM. Things we do for no reason – ordering Streptococcus pneumoniae urinary antigen in patients with community-acquired pneumonia. Open Forum Infect Dis. 2024;11(3):ofae089. Centers for Disease Control and Prevention. Laboratory Testing for Legionella. Updated June 9, 2025. Accessed July 13, 2025. https://www.cdc.gov/legionella/php/laboratories/index.html. Jain S, Self WH, Wunderink RG. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med. 2015;373(5):415-427. Kamat IS, Ramachandram V, Eswaran H, Guffey D, Musher DM. Procalcitonin to distinguish viral from bacterial pneumonia: a systematic review and meta-analysis. Clin Infect Dis. 2020;70(3):538-542. Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single blinded intervention trial. Lancet. 2004;363:600–7. doi: 10.1016/S0140- 6736(04)15591-8. Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I, et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA. 2009;302:1059–66. Schuetz P, Muller B, Christ-Crain M, Stolz D, Tamm M, Bouadma L, et al. Procalci- € tonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Datab System Rev. 2017;10(10):CD007498. doi: 10.1002/14651858. cd007498.pub2. Huang DT, Yealy DM, Filbin MR, Brown AM, Chang C-CH, Doi Y, et al. Procalcitonin-guided use of antibiotics for lower Respiratory tract infection. New Engl J Med. 2018;379:236–49. doi: 10.1056/NEJMoa1802670. Dequin PF, Meziani F, Quenot JP, et al. Hydrocortisone in severe community-acquired pneumonia. N Engl J Med. 2023;389(19):1623-1634. doi:10.1056/NEJMoa2215145. Gupta AB, Flanders SA, Petty LA, et al. Inappropriate diagnosis of pneumonia among hospitalized adults. JAMA Intern Med. 2024;184(5):548-556. Jones BE, Chapman AB, Ying J, et al. Diagnostic Discordance, Uncertainty, and Treatment Ambiguity in Community-Acquired Pneumonia: A National Cohort Study of 115 U.S. Veterans Affairs Hospitals. Ann Intern Med. 2024;177(9):1179-1189. doi:10.7326/M23-2505. Hartlage W, Imlay H, Spivak ES. The role of empiric atypical antibiotic coverage in non-severe community-acquired pneumonia. Antimicrob Steward Healthc Epidemiol. 2024;4(1):e214. doi:10.1017/ash.2024.453. Dinh A, Barbier F, Bedos JP, et al. Update of guidelines for management of community acquired pneumonia in adults by the French Infectious Disease Society (SPILF) and the French-Speaking Society of Respiratory Diseases (SPLF). Endorsed by the French Infectious Disease Society (SPILF) and the French-Speaking Society of Respiratory Diseases (SPLF); endorsed by the French Intensive Care Society (SRLF), the French Microbiology Society (SFM), the French Radiology Society (SFR), and the French Emergency Society (SFMU). Respir Med and Res. 2025. El Moussaoui R, de Borgie CAJM, van den Broek P, et al. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study. BMJ. 2006;332(7554):1355. doi:10.1136/bmj.332.7554.1355. Dinh A, Ropers J, Duran C, et al. Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia: a randomized, non-inferiority trial. Lancet. 2021;397(10280):1195-1203.

Dr. Joseph Kanter, ASTHO CEO, and Kate McEvoy, Executive Director of the National Association of Medicaid Directors, discuss a new partnership between the two organizations; Dr. Joseph Kanter, ASTHO CEO, Dr. Susan Kansagra, ASTHO Chief Medical Officer, Dr. Scott Harris, ASTHO President and State Health Officer for the Alabama Department of Public Health, Dr. Ayanna Bennett, Director of the District of Columbia Department of Health, and Dr. Manisha Juthani, ASTHO President-Elect and Commissioner for the Connecticut Department of Public Health, held a deskside briefing discussing ACIP recommendations amid preparations for the upcoming respiratory virus season; a new ASTHO report analyzes recent Medicaid data to determine causes of commercial tobacco use in Washington State; and ASTHO will host a webinar with the PHIG National Partners to introduce Wave 2 of the Public Health Data Modernization Implementation Center Program on August 26. NAMD Web Page: National Committee for Sustainable Medicaid and Public Health Partnerships ASTHO YouTube: ASTHO Respiratory Virus Season Deskside Media Briefing ASTHO Report: Tobacco Use in King County Washington: A Medicaid Data Analysis Report ASTHO Webinar: Public Health Data Modernization Implementation Center Program  

Dr. Joseph Kanter, ASTHO CEO, Dr. Susan Kansagra, ASTHO Chief Medical Officer, Dr. Scott Harris, ASTHO President and State Health Officer for the Alabama Department of Public Health, Dr. Ayanna Bennett, Director of the District of Columbia Department of Health, and Dr. Manisha Juthani, ASTHO President-Elect and Commissioner for the Connecticut Department of Public Health, held a deskside briefing on the preparations for the upcoming respiratory virus season; Ericka McGowan, Senior Director of Emerging Infectious Disease at ASTHO, explains the importance of case investigation and contact tracing, and how ASTHO's Foundations in CICT course can help prepare public health providers; a new ASTHO brief breaks down succession planning to help public health departments develop strategies to address workforce challenges; and ASTHO will hold the first webinar of a three-part series on Thursday, September 4th, to explore building a future-ready public health workforce through succession planning.  ASTHO Blog: Strengthening Case Investigation and Contact Tracing Skills: Q&A with Ericka McGowan ASTHO Brief: Demystifying Succession Planning ASTHO Webinar: Succession Planning Part 1 of 3: Building the Case for Succession Planning  

Bill is back on the podcast today, and we are talking more about hypochlorous acid, Curativa Bay's products, and some incredible health benefits we have personally seen in my own family. In our last chat, we covered how hypochlorous acid is made naturally in the body and how it may even help prevent Alzheimer's. This time, we talk about how Curativa Bay's formulas are different from others on the market, the importance of pH for product effectiveness, and how these products support everything from skin health and respiratory function to pet care and anti-aging. I also share some of my favorite go-to products and how we use them daily. Topics Discussed: → What is Curativa Bay's hypochlorous acid?→ How does it help skin health?→ Can it improve breathing?→ What pH makes it work best?→ Is it safe for pets?Sponsored By:→ Troscriptions | There's a completely new way to optimize your health. Give it a try at troscriptions.com/SARAHK, or enter SARAHK at checkout for 10% off your first order.→ Bon Charge | Click here & use code for SARAHKLEINER for 15% off storewide.→ Nutrisense | For 33% off all Nutrisense plans go to nutrisense.io/sarahk Code SarahK33 will be automatically applied at checkoutTimestamps:→ 00:00:00 - Introduction → 00:02:35 - How Curativa Bay is difference → 00:06:14 - Hypochlorous acid overview→ 00:09:48 - Hypochlorous acid uses→ 00:14:36 - Sugar, carbs, & alcohol→ 00:17:04 - Curativa Bay products  → 00:18:48 - Respiratory health → 00:23:01 - Anti aging & skin health → 00:26:41 - Curativa bay reviews → 00:28:27 - Pet health → 00:29:18 - “C” Silver → 00:32:11 - Heart attack treatment → 00:35:27 - Curativa Bay uses → 00:40:26 - Fatty 15 → 00:45:09 - Nattokinase Further Listening: → Healing Naturally with Hypochlorous Acid: Alzheimer's, Cancer, Eczema + More | Curativa BayCheck Out Curativa Bay:→ Go to https://www.curativabay.com Use Code SARAHK for a 10% offThis video is not medical advice & as a supporter to you and your health journey - I encourage you to monitor your labs and work with a professional!________________________________________My free product guide with all product recommendations and discount codes:https://s3.amazonaws.com/kajabi-storefronts-production/file-uploads/sites/2147573344/themes/2150788813/downloads/eac4820-016-b500-7db-ba106ed8583_2024_SKW_Affiliate_Guide_6_.pdfCheck out all my courses to understand how to improve your mitochondrial health & experience long lasting health! (Use code PODCAST to save 10%) -  https://www.sarahkleinerwellness.com/coursesSign up for my newsletter to get special offers in the future! -https://www.sarahkleinerwellness.com/contact